Last updated on November 2017

THR-1442-C-476


Brief description of study

THR-1442-C-476

Detailed Study Description

A double blind placebo controlled study to evaluate the effects of bexagliflozin on hemoglobin A1c in patients with type 2 diabetes and increased risk of cardiovascular adverse events.

Clinical Study Identifier: TX14918

Contact Investigators or Research Sites near you

Start Over

Denise Esparza

Diabetes Associates Medical Group / Clinical Research
Orange, CA USA